|
健保碼及健保價 |
|
See related Orfadin cap information |
|
|
|
製造商 |
Swedish |
|
代理/經銷商 |
TSPC |
|
成份 |
Nitisinone |
|
適應症 |
Adjunct to dietary restriction of tyrosine & phenylalanine in the treatment of hereditary tyrosinemia type 1. |
|
用量 |
Initially, 1 mg/kg/day in divided doses (morning & evening). If necessary, the dose may be increased after 1 month to 1.5 mg/kg/day; max daily dose: 2 mg/kg. |
|
注意事項 |
Monitor platelet & white blood cell counts during therapy; plasma tyrosine levels should be kept below 500 micromole/L in order to avoid toxic effects to the eyes, skin & nervous system; advise patient to consult a doctor immediately if they develop visual disturbances during treatment; regular liver monitoring by imaging & lab tests, including serum α-fetoprotein conc is recommended. |
|
不良反應 |
Alopecia, dry skin, exfoliative dermatitis, maculopapular rash, pruritis; leukopenia, thrombocytopenia, epistaxis, porphyria; conjunctivitis, corneal opacity, keratitis, photophobia; blepharitis, cataracts, eye pain; hepatic neoplasm, liver failure.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
本商品之市售規格 |
|
|
|
Manufacturer: |
Swedish |
|
Distributor: |
TSPC |
|
|
|
|
|